Inhibrx Biosciences, Inc.
Inhibrx Biosciences, Inc. (INBX) Stock Overview
Explore Inhibrx Biosciences, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
317.3M
P/E Ratio
0.20
EPS (TTM)
$119.02
ROE
11.01%
INBX Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Inhibrx Biosciences, Inc. (INBX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 50.11, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $25.12.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 0.20 and a market capitalization of 317.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.